Home › Borstkanker › Florida › Orlando
Borstkanker klinische studies in Orlando, FL
23 studies voor Borstkanker zoeken deelnemers op locaties in en rond Orlando (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- Advent Health, Orlando
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mijl verwijderd
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
RekruterenFase 3
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0024), Altamonte Springs · 9 mijl verwijderd
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruterenFase 3
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs · 9 mijl verwijderd
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruterenFase 3
- Orlando Health Cancer Institute ( Site 0011), Orlando
- AdventHealth Altamonte Springs ( Site 0021), Altamonte Springs · 9 mijl verwijderd
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruterenFase 3
- Research Site, Altamonte Springs · 9 mijl verwijderd
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- AdventHealth Altamonte Springs, Altamonte Springs · 9 mijl verwijderd
- Clermont Oncology Center, Clermont · 24 mijl verwijderd
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RekruterenFase 2
- AdventHealth Altamonte Springs, Altamonte Springs · 9 mijl verwijderd
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruterenFase 1/2
- Florida Cancer Specialists - Lake Nona, Orlando
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- AdventHealth Orlando Infusion Center, Orlando
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruterenFase 1
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
RekruterenFase 1
- Cancer Centers of Florida, Ocoee · 10 mijl verwijderd
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruterenFase 3
- AdventHealth, Altamonte Springs · 9 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- AdventHealth Orlando, Orlando
- Orlando Health Cancer Institute, Orlando
- AdventHealth Altamonte, Altamonte Springs · 9 mijl verwijderd
- en nog 1
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruterenFase 3
- Advent Health - Orlando, Orlando
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- AdventHealth Orlando, Orlando
- Orlando Health Cancer Institute, Orlando
- AdventHealth Altamonte, Altamonte Springs · 9 mijl verwijderd
- en nog 1
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RekruterenFase 1/2
- Florida Cancer Specialists, Orlando
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruterenObservatieonderzoek
- AdventHealth East Altamonte Oncology and Hematology, Altamonte Springs · 9 mijl verwijderd
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Adventhealth, Orlando
UCF MammoChat: Image Repository
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- University of Central Florida, Orlando
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
RekruterenFase 1
- Florida Cancer Specialists, Orlando
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #8, Orlando
Borstkanker studies in andere steden
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Orlando
- Niet-kleincellige longkanker44 studies
- Obesitas31 studies
- Metastatische kanker29 studies
- Overgewicht27 studies
- Ziekte van Alzheimer25 studies
- Type 2-diabetes24 studies
- Kanker (alle vormen)24 studies
- Eierstokkanker22 studies
- Colitis ulcerosa22 studies
- Longkanker21 studies
- Colorectale kanker19 studies
- Ernstige depressieve stoornis19 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.